X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs AJANTA PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD AJANTA PHARMA MERCK LTD/
AJANTA PHARMA
 
P/E (TTM) x 34.2 28.3 120.6% View Chart
P/BV x 3.8 11.7 32.8% View Chart
Dividend Yield % 0.7 0.5 143.9%  

Financials

 MERCK LTD   AJANTA PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
AJANTA PHARMA
Mar-16
MERCK LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,720 61.6%   
Low Rs6231,103 56.5%   
Sales per share (Unadj.) Rs632.4194.6 325.0%  
Earnings per share (Unadj.) Rs45.745.2 101.1%  
Cash flow per share (Unadj.) Rs62.350.3 123.9%  
Dividends per share (Unadj.) Rs11.008.00 137.5%  
Dividend yield (eoy) %1.30.6 230.6%  
Book value per share (Unadj.) Rs388.8132.0 294.5%  
Shares outstanding (eoy) m16.6088.77 18.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.37.3 18.3%   
Avg P/E ratio x18.431.2 59.0%  
P/CF ratio (eoy) x13.528.1 48.1%  
Price / Book Value ratio x2.210.7 20.2%  
Dividend payout %24.117.7 136.0%   
Avg Mkt Cap Rs m13,969125,299 11.1%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4872,570 57.9%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,49817,275 60.8%  
Other income Rs m242166 145.8%   
Total revenues Rs m10,74117,442 61.6%   
Gross profit Rs m1,1355,807 19.5%  
Depreciation Rs m276451 61.1%   
Interest Rs m049 0.0%   
Profit before tax Rs m1,1025,474 20.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,460 23.5%   
Profit after tax Rs m7594,014 18.9%  
Gross profit margin %10.833.6 32.2%  
Effective tax rate %31.126.7 116.8%   
Net profit margin %7.223.2 31.1%  
BALANCE SHEET DATA
Current assets Rs m6,4107,639 83.9%   
Current liabilities Rs m8,8282,715 325.2%   
Net working cap to sales %-23.028.5 -80.8%  
Current ratio x0.72.8 25.8%  
Inventory Days Days5843 133.4%  
Debtors Days Days3879 48.8%  
Net fixed assets Rs m1,4066,914 20.3%   
Share capital Rs m166177 93.8%   
"Free" reserves Rs m6,28611,442 54.9%   
Net worth Rs m6,45511,721 55.1%   
Long term debt Rs m0149 0.0%   
Total assets Rs m8,82814,814 59.6%  
Interest coverage xNM112.9-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.21.2 102.0%   
Return on assets %8.627.4 31.3%  
Return on equity %11.834.2 34.3%  
Return on capital %17.146.5 36.7%  
Exports to sales %8.355.1 15.0%   
Imports to sales %21.06.0 350.4%   
Exports (fob) Rs m8699,527 9.1%   
Imports (cif) Rs m2,2091,038 212.9%   
Fx inflow Rs m95910,422 9.2%   
Fx outflow Rs m2,6121,678 155.6%   
Net fx Rs m-1,6538,744 -18.9%   
CASH FLOW
From Operations Rs m1,0703,264 32.8%  
From Investments Rs m-750-2,093 35.8%  
From Financial Activity Rs m-150-1,186 12.6%  
Net Cashflow Rs m171-15 -1,154.7%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 1.6 1,174.2%  
FIIs % 1.0 7.6 13.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.0 171.2%  
Shareholders   28,591 20,968 136.4%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 19, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - PFIZER COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS